Tailor-Made vaccine targets advanced cancers in first human test
NCT ID NCT03568058
First seen Mar 25, 2026 · Last updated May 20, 2026 · Updated 9 times
Summary
This study tested a personalized vaccine made for each patient's unique cancer. It included 25 adults with advanced solid tumors who had no other treatment options. The goal was to see if making and giving the vaccine was safe and possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCSD Medical Center
San Diego, California, 92103, United States
Conditions
Explore the condition pages connected to this study.